{
      "Rank": 107,
      "Acronym": [
            "LC"
      ],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "only apply for conventional medical therapy without any cell therapy",
            "combination of conventional therapy with umbilical mesenchymal stem cells intravenous injection, (4x107/40ml, once per three months, four times in one year)"
      ],
      "ArmGroupInterventionName": [
            "Biological: Conventional therapy",
            "Biological: mesenchymal stem cells"
      ],
      "ArmGroupLabel": [
            "Conventional therapy",
            "mesenchymal stem cells"
      ],
      "ArmGroupType": [
            "Sham Comparator",
            "Active Comparator"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT01573923"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "Liver cirrhosis and subsequent liver failure are leading causes of morbidity and mortality worldwide. Alcohol abuse and viral hepatitis are the most common causes of cirrhosis. Novel therapies are necessary to prevent or block the process of the disease. In this current prospective cohort, the investigators plan to organize four hospitals to determine the safety and efficacy of intravenous administration of umbilical mesenchymal stem cells in the treatment of patients with liver cirrhosis in next three years."
      ],
      "BriefTitle": [
            "Safety and Efficacy Study of Umbilical Mesenchymal Stem Cells for Liver Cirrhosis"
      ],
      "CentralContactEMail": [
            "peixt@nic.bmi.ac.cn",
            "jihaijie82@sohu.com"
      ],
      "CentralContactName": [
            "Xuetao Pei, MD,PhD",
            "Haijie Ji, MD"
      ],
      "CentralContactPhone": [
            "86-10-68214650",
            "86-10-63188853"
      ],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [
            "Contact",
            "Contact"
      ],
      "CollaboratorClass": [],
      "CollaboratorName": [],
      "CompletionDate": [
            "October 2015"
      ],
      "CompletionDateType": [
            "Anticipated"
      ],
      "Condition": [
            "Liver Cirrhosis"
      ],
      "ConditionAncestorId": [
            "D000010335",
            "D000008107",
            "D000004066"
      ],
      "ConditionAncestorTerm": [
            "Pathologic Processes",
            "Liver Diseases",
            "Digestive System Diseases"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC06",
            "BC23",
            "All"
      ],
      "ConditionBrowseBranchName": [
            "Digestive System Diseases",
            "Symptoms and General Pathology",
            "All Conditions"
      ],
      "ConditionBrowseLeafAsFound": [
            "Liver Cirrhosis",
            "Cirrhosis"
      ],
      "ConditionBrowseLeafId": [
            "M10255",
            "M7637",
            "M10259",
            "M8035",
            "M6407"
      ],
      "ConditionBrowseLeafName": [
            "Liver Cirrhosis",
            "Fibrosis",
            "Liver Diseases",
            "Gastrointestinal Diseases",
            "Digestive System Diseases"
      ],
      "ConditionBrowseLeafRelevance": [
            "high",
            "high",
            "low",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000008103",
            "D000005355"
      ],
      "ConditionMeshTerm": [
            "Liver Cirrhosis",
            "Fibrosis"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "Non-Randomized"
      ],
      "DesignInterventionModel": [
            "Parallel Assignment"
      ],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [
            "None (Open Label)"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [],
      "DetailedDescription": [],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nwritten informed consent\naged 30-60 years\nclinical diagnosis of compensated or decompensated liver\nchild-Pugh B/C (7-12 points)\nexpecting lifetime is over three years\n\nExclusion Criteria:\n\npregnant woman\npatient with severe vascular diseases\npatient with any organ failure\npatient with any tumors\npatient with HIV\npatient who has been transplanted\npatient treated with immunosuppressors\npatient for whom the follow-up is considered impossible\npatients with any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the subject"
      ],
      "EnrollmentCount": [
            "320"
      ],
      "EnrollmentType": [
            "Anticipated"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [],
      "InterventionAncestorTerm": [],
      "InterventionArmGroupLabel": [
            "mesenchymal stem cells",
            "Conventional therapy"
      ],
      "InterventionBrowseBranchAbbrev": [
            "Hemat",
            "All"
      ],
      "InterventionBrowseBranchName": [
            "Hematinics",
            "All Drugs and Chemicals"
      ],
      "InterventionBrowseLeafAsFound": [],
      "InterventionBrowseLeafId": [
            "M10262"
      ],
      "InterventionBrowseLeafName": [
            "Liver Extracts"
      ],
      "InterventionBrowseLeafRelevance": [
            "low"
      ],
      "InterventionDescription": [
            "Conventional therapy plus UC-MSC intravenous administration (4x107/40ml, once per three months, four times in one year)",
            "Conventional therapy without cell therapy"
      ],
      "InterventionMeshId": [],
      "InterventionMeshTerm": [],
      "InterventionName": [
            "mesenchymal stem cells",
            "Conventional therapy"
      ],
      "InterventionOtherName": [],
      "InterventionType": [
            "Biological",
            "Biological"
      ],
      "IsFDARegulatedDevice": [],
      "IsFDARegulatedDrug": [],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [
            "Umbilical Mesenchymal Stem Cells; Liver cirrhosis"
      ],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [
            "Recruiting"
      ],
      "LastUpdatePostDate": [
            "April 14, 2015"
      ],
      "LastUpdatePostDateType": [
            "Estimate"
      ],
      "LastUpdateSubmitDate": [
            "April 12, 2015"
      ],
      "LeadSponsorClass": [
            "INDUSTRY"
      ],
      "LeadSponsorName": [
            "Alliancells Bioscience Corporation Limited"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Beijing",
            "Lanzhou",
            "Qionghai",
            "Lianyungang",
            "Shanghai",
            "Xi'an"
      ],
      "LocationContactEMail": [
            "Jiang.st@hotmail.com",
            "wanglm@fmmu.edu.cn"
      ],
      "LocationContactName": [
            "Hanwei Li, MD, PhD",
            "Xun Li, MD, PhD",
            "Xun Li, MD",
            "Jiang Shu",
            "Hui Shi, MD",
            "Hui Shi, MD",
            "Liming Chen, MD, PhD",
            "Jianwei Lu, PhD",
            "Liming Wang, MD",
            "Liming Wang, MD"
      ],
      "LocationContactPhone": [
            "86-29-84756502"
      ],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [
            "Principal Investigator",
            "Contact",
            "Principal Investigator",
            "Contact",
            "Contact",
            "Principal Investigator",
            "Contact",
            "Principal Investigator",
            "Contact",
            "Principal Investigator"
      ],
      "LocationCountry": [
            "China",
            "China",
            "China",
            "China",
            "China",
            "China"
      ],
      "LocationFacility": [
            "The 302 Hospital of Chinese People's Liberation Army",
            "the First Affiliated Hospital of Lanzhou University",
            "Hainan BOAO Life infinity international anti-aging medical center",
            "The first people's hospital of Lianyungang",
            "Tongji Hospital of Tongji University",
            "The 323 Hospital of Chinese People's Liberation Army"
      ],
      "LocationState": [
            "Beijing",
            "Gansu",
            "Hainan",
            "Jiangsu",
            "Shanghai",
            "Shanxi"
      ],
      "LocationStatus": [
            "Recruiting",
            "Recruiting",
            "Recruiting",
            "Recruiting",
            "Recruiting",
            "Recruiting"
      ],
      "LocationZip": [
            "571434",
            "222002",
            "710054"
      ],
      "MaximumAge": [
            "60 Years"
      ],
      "MinimumAge": [
            "30 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "Clinical Trial of Umbilical Mesenchymal Stem Cells Transplantation for Liver Cirrhosis-Phase I/II"
      ],
      "OrgClass": [
            "INDUSTRY"
      ],
      "OrgFullName": [
            "Alliancells Bioscience Corporation Limited"
      ],
      "OrgStudyId": [
            "Alliancells-2012-1"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "Chinese Industry and Innovative Technology Strategic Alliance of Stem Cells and Regenerative Medicine",
            "Alliancells Bioscience Corporation Limited",
            "Eastern Union Stem Cell & Gene Engineering Co.,Ltd\uff0c Alliancells Bioscience Corporation Limited",
            "The 302 Hospital of Chinese People's Liberation Army",
            "The 323 Hospital of Chinese People's Liberation Army",
            "LanZhou University",
            "ongji Hospital of Tongji University",
            "Tongji Hospital",
            "The First People's Hospital of Lianyungang"
      ],
      "OverallOfficialName": [
            "Xuetao Pei, MD,PhD",
            "Yongjun Liu, MD,PhD",
            "Mingyuan Wu, MD,PhD",
            "Hanwei Li, MD,PhD",
            "Liming Wang, MD",
            "Xun Li, MD,PhD",
            "Liming Chen, MD,PhD",
            "Jianwei Lu, MD",
            "Hui Shi, MD"
      ],
      "OverallOfficialRole": [
            "Study Chair",
            "Study Director",
            "Study Director",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator",
            "Principal Investigator"
      ],
      "OverallStatus": [
            "Unknown status"
      ],
      "OversightHasDMC": [
            "No"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Phase 1",
            "Phase 2"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "July 2015"
      ],
      "PrimaryCompletionDateType": [
            "Anticipated"
      ],
      "PrimaryOutcomeDescription": [],
      "PrimaryOutcomeMeasure": [
            "survival time"
      ],
      "PrimaryOutcomeTimeFrame": [
            "3-year follow up"
      ],
      "ReferenceCitation": [],
      "ReferencePMID": [],
      "ReferenceType": [],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [],
      "ResponsiblePartyInvestigatorFullName": [],
      "ResponsiblePartyInvestigatorTitle": [],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Sponsor"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [
            "liver functions\uff1aAlbumin (ALB), Alanine aminotransferase (ALT), Aspartate Aminotransferase (AST), Prealbumin(PA), total bilirubin (TB), and direct bilirubin (DB) kidney function\uff1aBlood urea nitrogen (BUN), Urea (UA), and Crea (Cr)",
            "Total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), triglycerides (TG), very low density lipoprotein cholesterol (VLDL-C), and Non-HDL-C; blood sugar;",
            "IL-1\u03b2, IL-4, IL-6, IL-8, IL-10, IL-12(p40), IL-15, IL-17A, TNF\u03b1, TNF\u03b2, IFN-\u03b3, RANTES, TGF\u03b2, lymphotactin, and C-reactive protein level (CRP)",
            "Serum levels of Hepatitis B and C",
            "The classification for uncomfortable reaction is: 0, no discomfort; 1, slightly unwell, does not affect daily life; 2, moderate discomfort, affects daily life and work; 3, moderately unwell, significantly affects life, and bed rest; 4, severely unwell, life-threatening.\n\nA serious adverse event is defined as fatal, life threatening, permanently disabling, and tumors, particularly hepatocellular carcinoma.",
            "abdominal distension, appetite, debilitation, and edema of lower limbs."
      ],
      "SecondaryOutcomeMeasure": [
            "Serum markers regarding liver and kidney function",
            "Serum markers regarding lipid and sugar profile",
            "Serum markers regarding cytokine profile",
            "Serum levels of Hepatitis B and C",
            "tolerance and the adverse events",
            "Changes of any clinical symptoms"
      ],
      "SecondaryOutcomeTimeFrame": [
            "0, 3, 6, 9 and 12 months",
            "0, 3, 6, 9 and 12 months",
            "0, 3, 6, 9 and 12 months",
            "0, 3, 6, 9 and 12 months",
            "3-year follow up",
            "3-year follow up"
      ],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "July 2014"
      ],
      "StartDateType": [],
      "StatusVerifiedDate": [
            "April 2012"
      ],
      "StdAge": [
            "Adult"
      ],
      "StudyFirstPostDate": [
            "April 10, 2012"
      ],
      "StudyFirstPostDateType": [
            "Estimate"
      ],
      "StudyFirstSubmitDate": [
            "April 6, 2012"
      ],
      "StudyFirstSubmitQCDate": [
            "April 9, 2012"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 10, 2022"
      ],
      "WhyStopped": []
}